Alzheimer’s

InMed Pharmaceuticals (INM) Soars on Alzheimer’s Breakthrough: INM‑901 Study Sparks 20%+ Stock Rally on November 20, 2025

InMed Pharmaceuticals Inc. (NASDAQ: INM) is back in the spotlight today after a sharp bounce in its share price, driven by fresh preclinical data for its Alzheimer’s disease candidate INM‑901 and heavy speculative trading in the micro‑cap biotech name. On Wednesday, INM shares closed at $1.23, down almost 16% on the day, before surging about 22% after hours to around $1.50. Benzinga That momentum rolled into Thursday’s pre‑market session, where multiple market data sources showed gains of roughly 20–26%, with INM changing hands in the $1.49–$1.55 range on unusually high volume. Benzinga+2RTTNews+2 As regular trading gets underway, real‑time quote providers

20 November 2025

Anavex Life Sciences (AVXL) Stock Plunges After EMA Issues Negative Trend Vote on Alzheimer’s Drug

Anavex Life Sciences (NASDAQ: AVXL) tumbled on November 14, 2025 after Europe’s drug regulator delivered a negative trend vote on its Alzheimer’s candidate blarcamesine. The company plans a CHMP re-examination and a fresh meeting with the FDA. Here’s what happened and what comes next. By Staff Reporter — November 14, 2025 NEW YORK — Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) were under heavy pressure on Friday after the European Medicines Agency’s human medicines committee signaled it is leaning against approving the company’s experimental Alzheimer’s pill blarcamesine for early Alzheimer’s disease. Investing News Network (INN)+1 The Committee for Medicinal

14 November 2025

Alzheimer’s Disease · Biotech News · Investment Analysis · NASDAQ:AVXL · Pharmaceuticals · Stock Market

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly (LLY) Surges on Obesity Drug Boom and Alzheimer’s Breakthroughs – Is $1,000 Next?

LLY Stock Skyrockets, Then Dips on Pricing Jitters Eli Lilly’s stock has been on a tear in 2025, powered by optimism around its new drug innovations. Shares surged dramatically at the start of October – leaping from about $726 at the end of September to as high as $832 by October 1 ts2.tech. This double-digit jump in just days far outpaced the broader market and reflected euphoric sentiment toward Lilly’s growth prospects ts2.tech. Analysts attributed the rally to a perfect storm of positive news: strong recent earnings, insider buying, and fresh research fueling excitement about Lilly’s obesity and Alzheimer’s franchises

17 October 2025

Alzheimer’s Research · Investment Analysis · NYSE:LLY · Obesity Treatment · Pharmaceuticals · Stock Market

Ozempic for Alzheimer’s? How GLP-1 Weight-Loss Drugs Could Fight Neurodegenerative Diseases

GLP-1 Receptor Agonists and Neurodegenerative Diseases in 2025 GLP-1 receptor agonists like semaglutide (Ozempic®) are typically given via a weekly injection pen. Originally developed for diabetes and obesity, these drugs are now being studied for their effects on the brain. From Diabetes to Dementia: Why GLP-1 Drugs Are Being Tested for Brain Diseases Just a few years ago, GLP-1 receptor agonists were known mainly as diabetes and weight-loss medications. GLP-1 (glucagon-like peptide-1) is a natural hormone that helps regulate blood sugar and appetite. Drugs like Ozempic (semaglutide) and Victoza (liraglutide) mimic this hormone, improving insulin release and promoting a feeling

10 September 2025

Alzheimer’s · GLP-1 Drugs · Medicine · Neurodegenerative Diseases · NYSE:NVO · Weight Loss

Mars’ Core Revealed, “Pristine” Galaxy Spotted, Alzheimer’s Test Hope, and a Quantum Leap – Science News Roundup (Sept 4–5, 2025)

Space & Astronomy Marsquakes Confirm Mars Has a Solid Metal Core Seismic readings from NASA’s InSight Mars lander have revealed that Mars possesses a solid inner core, much like Earth’s. A Chinese-led team analyzed faint marsquake waves and found Mars’ inner core extends ~613 km (~380 mi) from the center, likely made of iron and nickel, surrounded by a molten outer core phys.org. Previously, scientists suspected Mars’ core was fully liquid; this new finding (published in Nature) confirms a small solid center. “Our results suggest that Mars has a solid inner core making up about one-fifth of the planet’s radius – roughly

5 September 2025

Astronomy · Mars · Neuroscience · Quantum Physics · Science News

Alzheimer’s At-Home Shot Approved, Bird Flu Scare, and CDC Shake-Up – Global Biotech & Health Roundup (Aug 29–30, 2025)

Key Facts Scientific Breakthroughs & New Research Leading our roundup are several significant scientific and medical breakthroughs. Researchers in New York unveiled a potential “universal” antiviral strategy, reporting compounds that neutralized seven different viruses across multiple families in lab tests gavi.org. By targeting sugar molecules (glycans) common to many enveloped viruses, the team identified four small molecules that blocked infections by pathogens ranging from coronaviruses to Nipah and Ebola gavi.org. “This is the kind of antiviral tool the world urgently needs. If a new virus emerges tomorrow, we currently have nothing to deploy. These compounds offer the potential to be

30 August 2025

Biotech · Global News · Health · Medicine · NASDAQ:CYTK · NYSE:GSK · NYSE:SNY · Public Health

COVID Booster Shocker, Pharma Mega-Deals & Alzheimer’s Breakthroughs – Global Health Roundup (Aug 28–29, 2025)

Drug Approvals & Clinical Trial Results Updated COVID Boosters Get Narrow Nod: The U.S. FDA approved new fall COVID-19 booster shots from Pfizer/BioNTech and Moderna on August 27 – but with strict eligibility limits. Only adults 65+ and younger people with certain medical conditions are cleared for the updated vaccines, and emergency use authorizations for routine use in healthy children were removed realeconomy.rsmus.com. Health experts immediately sounded alarms: the Infectious Diseases Society of America blasted the “narrowed” booster rollout as contrary to scientific guidance and a risk to lives cidrap.umn.edu. They warn these restrictions could hinder access, especially for children,

29 August 2025

COVID-19 · Global Health · Health News · Medical Breakthroughs · NASDAQ:AMLX · NASDAQ:OTLK · NASDAQ:PRTA · NYSE:NVO · NYSE:WBA · Pharmaceuticals